Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.

Wang, Yaping; Bi, Minghong; Zhang, Haoran; Gao, Zhenyuan; Zhou, Hairong; Chang, Shu

Wang, Yaping; Bi, Minghong; Zhang, Haoran; Gao, Zhenyuan; Zhou, Hairong; Chang, Shu.

Afiliação

Wang Y; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China.
Bi M; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China.
Zhang H; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China.
Gao Z; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China.
Zhou H; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China.
Chang S; Department of Library, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China.

Asia Pac J Clin Oncol ; 13(5): e528-e530, 2017 Oct.

Article em En | MEDLINE | ID: mdl-28028915

Assuntos

Antineoplásicos/uso terapêutico; Piridinas/uso terapêutico; Neoplasias Gástricas/tratamento farmacológico; Idoso de 80 Anos ou mais; Antineoplásicos/administração & dosagem; Antineoplásicos/farmacologia; China; Intervalo Livre de Doença; Humanos; Masculino; Piridinas/administração & dosagem; Piridinas/farmacologia; Neoplasias Gástricas/patologia

Palavras-chave

advanced gastric cancer; apatinib; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Gástricas / Antineoplásicos Limite: Aged80 / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Asia Pac J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google